Patient outcomes
| Benchmark scenario | Scenario 1 (Plan A) | Scenario 2 (Plan B) | Scenario 3 (Plan C) | |
| Exacerbation-related outputs | ||||
| No. of admissions | 395.1 | 327.8 | 305.2 | 284.1 |
| No. of used bed days | 2344.4 | 1972.6 | 1830.0 | 1707.2 |
| No. of deaths | 25.4 | 24.9 | 23.6 | 20.5 |
| Change in QALYs | ||||
| via LF testing | 2.39 | 0.84 | 0.46 | 0.11 |
| via PR | 2.25 | 2.93 | 3.03 | 2.84 |
| via exacerbation | −22.77 | −18.89 | −17.59 | −16.37 |
| Total change in QALYs* | −18.14 | −15.13 | −14.10 | −13.42 |
*The total represents COPD management-related QALY changes and does not include changes in mental and physical health due to the restrictions.
COPD, chronic obstructive pulmonary disease; LF, lung function; PR, pulmonary rehabilitation; QALYs, quality-adjusted life years.